Laurus Labs Share Price
- All
- News
-
These 5 Companies' Capital Expenditure Plans Are Nearing Completion
Tracking a company's capex plans provides information about its growth prospects and indicates the managements outlook.
-
Laurus Labs Gains On Receiving License To Market Anti-Covid Drug 2DG
Laurus Labs shares have so far this year surged a whopping 95 per cent, outperforming the Sensex which has advanced 10 per cent.
-
Laurus Labs Shares Surge On Credit Rating Upgrade
CARE Ratings upgraded Laurus Labs' Long Term Bank Facilities worth Rs 1,930.64 crore to CARE AA Stable from CARE AA-.
-
Laurus Labs Gains Over 2% On Richcore Lifesciences Acquisition
Laurus Labs acquired a 72.55 per cent stake in biotech company, Richcore Lifesciences from Eight Roads Ventures and VenturEast for Rs 246.67 crore.
-
Laurus Labs IPO Fully Subscribed
Laurus Labs was selling up to Rs 300 crore in new shares and some its shareholders were selling about 24.1 million shares in a price range of Rs 426 to Rs 428 per share.
-
These 5 Companies' Capital Expenditure Plans Are Nearing Completion
Tracking a company's capex plans provides information about its growth prospects and indicates the managements outlook.
-
Laurus Labs Gains On Receiving License To Market Anti-Covid Drug 2DG
Laurus Labs shares have so far this year surged a whopping 95 per cent, outperforming the Sensex which has advanced 10 per cent.
-
Laurus Labs Shares Surge On Credit Rating Upgrade
CARE Ratings upgraded Laurus Labs' Long Term Bank Facilities worth Rs 1,930.64 crore to CARE AA Stable from CARE AA-.
-
Laurus Labs Gains Over 2% On Richcore Lifesciences Acquisition
Laurus Labs acquired a 72.55 per cent stake in biotech company, Richcore Lifesciences from Eight Roads Ventures and VenturEast for Rs 246.67 crore.
-
Laurus Labs IPO Fully Subscribed
Laurus Labs was selling up to Rs 300 crore in new shares and some its shareholders were selling about 24.1 million shares in a price range of Rs 426 to Rs 428 per share.
